Author | Deepa Jeyakumar, MD


The Next Generation of Targeted Molecules for the Treatment of Chronic Lymphocytic Leukemia

November 15, 2016

This article describes the clinical data that led to approval of these B-cell receptor inhibitors for the treatment of CLL, and highlights newer agents in clinical development that target the same kinases as the currently available therapies.